C4 Therapeutics Inc
NASDAQ:CCCC

Watchlist Manager
C4 Therapeutics Inc Logo
C4 Therapeutics Inc
NASDAQ:CCCC
Watchlist
Price: 2.34 USD -1.68% Market Closed
Market Cap: 217.4m USD
Have any thoughts about
C4 Therapeutics Inc?
Write Note

Wall Street
Price Targets

CCCC Price Targets Summary
C4 Therapeutics Inc

Wall Street analysts forecast CCCC stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for CCCC is 12.24 USD with a low forecast of 6.06 USD and a high forecast of 30.45 USD.

Lowest
Price Target
6.06 USD
159% Upside
Average
Price Target
12.24 USD
423% Upside
Highest
Price Target
30.45 USD
1 201% Upside
C4 Therapeutics Inc Competitors:
Price Targets
STOK
Stoke Therapeutics Inc
26% Upside
4BB
4Basebio PLC
121% Upside
6855
Ascentage Pharma Group International
70% Upside
4584
Kidswell Bio Corporation
87% Upside
GNTA
Genenta Science SPA
831% Upside
SKYE
Skye Bioscience Inc
481% Upside
DAWN
Day One Biopharmaceuticals Inc
144% Upside
MGX
Metagenomi Inc
372% Upside

Revenue
Forecast

Revenue Estimate
C4 Therapeutics Inc

For the last 5 years the compound annual growth rate for C4 Therapeutics Inc's revenue is 11%. The projected CAGR for the next 3 years is -13%.

11%
Past Growth
-13%
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Operating Income
Forecast

Operating Income Estimate
C4 Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
0%
Average Miss

Net Income
Forecast

Net Income Estimate
C4 Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-48%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is CCCC's stock price target?
Price Target
12.24 USD

According to Wall Street analysts, the average 1-year price target for CCCC is 12.24 USD with a low forecast of 6.06 USD and a high forecast of 30.45 USD.

What is C4 Therapeutics Inc's Revenue forecast?
Projected CAGR
-13%

For the last 5 years the compound annual growth rate for C4 Therapeutics Inc's revenue is 11%. The projected CAGR for the next 3 years is -13%.

Back to Top